Catalyst Biosciences Inc buy Wedbush
Start price
14.07.25
/
50%
€0.52
Target price
14.07.26
€23.10
Performance (%)
-
End price
15.07.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Wedbush for this prediction
In the thread Catalyst Biosciences Inc diskutieren
Crescent Biopharma, Inc. (NASDAQ: CBIO) is now covered by analysts at Wedbush. They set an "outperform" rating and a $27.00 price target on the stock.
Ratings data for CBIO provided by MarketBeat
In the thread Trading Catalyst Biosciences Inc
Die von Wedbush gewählte maximale Laufzeit wurde überschritten